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Objectives: To clarify the time-course changes in left ventricular myocardial deformation using velocity vector
imaging and to provide insights into our understanding of the cardiac pathophysiology in diabetes mellitus.
Methods: Thirty New Zealand white rabbits were randomly divided into either the control group (n = 10) or the
diabetes mellitus (DM) group (induced with STZ, n = 20). For the myocardial deformation studies, echocardiography
and syngo-vector velocity imaging (VVI) were performed at baseline and after 2, 4, 8, and 12 weeks in all of the
rabbits. The left ventricular (LV) global longitudinal and circumferential strain and strain rate were measured. For
histomorphological study of the heart structure, 2 of the STZ-induced rabbits were killed at 2, 4, 8, and 12 weeks.
Routine hematoxylin and eosin staining was performed.
Results: At 2 weeks, the global longitudinal strain (GLS), systolic strain rate (GLSRs), and diastolic strain rate (GLSRd)
were significantly lower in the DM group compared with the control group (−18.16% versus −24.00%, −1.86 s−1
versus −2.49 s−1, 1.93 s−1 versus 2.42 s−1, respectively, P < 0.05), while, compared with the control group, the global
circumferential strain (GCS), systolic strain rate (GCSRs), and diastolic strain rate (GCSRd) in the DM group were
significantly decreased (−12.77% versus −23.31%, −1.31 s−1 versus −2.20 s−1, 1.41 s−1 versus 2.15 s−1, respectively,
P < 0.05) at 8 weeks. With the progression of untreated diabetes, the histoanatomical alterations intensified
gradually beginning at 2 weeks.
Conclusions: The progressive impairments in LV myocardial deformation and structure occurred early in diabetic
rabbits with normal LV ejection fraction (EF), FS, and E/A. VVI could be used to evaluate subtle cardiac dysfunction
in the early phase of DM.
Keywords: DM, Myocardial deformation, VVI, STZ-induced rabbitsDiabetes mellitus is among the most common chronic
diseases worldwide. It has been estimated that there will
be 340 million people suffering from DM by 2030 [1].
Cardiovascular complications are the major morbidity and
cause of mortality in type 1 diabetes mellitus (T1DM).
Moreover, once cardiovascular disease is clinically mani-
fested, DM remains an independent risk factor for adverse
outcomes [2,3]. Early detection of diabetic heart disease is
important for timely interventions that prevent the future
development of heart failure. Therefore, it is crucial to* Correspondence: hnzqc2013@163.com
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early development of T1DM.
Vector velocity imaging (VVI) is a novel speckle
tracking-based technique for analyzing myocardial tissue
motion and velocity, without the limitations of Doppler
echocardiography [4-7]. This imaging is achieved via a
combination of speckle tracking, mitral annulus motion,
tissue-blood border detection, and the periodicity of the
cardiac cycle. It enables rapid and accurate quantitative
assessment of global and regional myocardial function, in
terms of myocardial velocities, strain (myocardial tissue
deformation), and strain rate (deformation rate). The tech-
nique provides an intuitive analysis of myocardial me-
chanics. Few studies have used speckle derived strain echotd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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diabetes [8-11], but no reports have shown a trend in
myocardial deformation changes in the very early stages
of T1DM. The studies by Wei Z et al. [8,9] showed that
circumferential strain and strain rate decreased in dia-
betic rats at 12 weeks after STZ induction. The study by
Nakai H et al [12] showed that diabetic duration was
the only independent confounder in the reduction of
longitudinal strain. Thus, we hypothesized that cardiac
dysfunction perhaps already exists in the very early stages
of T1DM.
The purposes of this study were to clarify the time
course changes in left ventricular myocardial deformation
in STZ-induced diabetic rabbits using VVI, to provide in-
sights into the pathophysiology of diabetic cardiomyop-
athy and to demonstrate the validity of VVI in identifying
heart structure alterations in T1DM.Materials and methods
Experimental animals
The experimental design was approved by the Central
South University Animal Care and Use Committee. The
institution’s guidelines for the care and use of laboratory
animals were observed.
STZ, a nitrosourea derivative that is able to increase
DNA alkylation, is the most commonly used drug to
induce type 1 diabetes in animal models [13]. GLUT2-
mediated transport of STZ in β-cells leads to multiple
DNA strand breaks [14] and subsequent activation of
poly-ADP-ribosylation. These events are followed by de-
pletion of intracellular NAD and ATP, and the insulin-
secreting cells undergo necrosis [15]. This immune
response resembles the pathophysiology of human type 1
diabetes. Therefore, STZ-diabetic animals, including ro-
dents, rabbits, monkeys, and pigs, have been used for de-
cades to investigate the systemic cardiovascular features of
type 1 diabetes.
The animals used were 30 male New Zealand rabbits
with a mean body mass of 2000 g. We chose only male
rabbits for the study because in our preliminary study,
compared with the female rabbit model, the male rabbit
model tended to have a higher success rate and a lower
mortality rate. The rabbits were randomly divided into
the DM group (n = 20) and the control group (n = 10).
Diabetes was induced by a single injection of STZ
(65 mg/kg) (1% STZ solution, diluted with 0.1 M citrate
buffer, pH 4.4, before injection) via the ear vein after a
12-hour fast. The control animals were injected with a
similar volume of citrate buffer solution. All of the rab-
bits were fed a standard diet and were provided water
ad libitum. Glucose concentrations and body mass were
monitored weekly and at the time of kill (after 2, 4, 8,
and 12 weeks of disease induction).Echocardiography
All of the rabbits underwent routine echocardiography,
tissue Doppler imaging and syngo-VVI prior to and at 2,
4, 8, and 12 weeks after the injections. These procedures
were performed by a single experienced operator (T.J.)
who was blinded to the group status of the subjects, the
stage of the study, and the previous measurements. All
of the rabbits were anesthetized by intraperitoneal injec-
tion of 3% sodium pentobarbital (1 mL/kg) and were
placed in a supine position with the anterior chest hair
removed. A complete echocardiogram was performed
using a Siemens Acuson S2000 system (Mountain View,
CA, USA) coupled to a 10V4C transducer. Multiple
two-dimensional (2D) views of the heart were obtained
to evaluate the cardiac anatomy. At least three consecu-
tive heartbeats were analyzed, with the values repre-
sented as the mean values. Heart rate, LA diameter, LV
end-systolic and end-diastolic diameters, interventricular
septum (IVS) thickness, and left ventricular posterior wall
(LVPW) thickness were measured by M-mode echocardi-
ography. Left ventricular ejection fraction (LVEF) was cal-
culated by the modified Simpson’s method. Transmitral
flow velocities were obtained by pulsed-wave Doppler
echocardiography by positioning a sample volume at
the level of the mitral tip. The peak velocities during
early diastole (E) and late diastole (A) were measured,
and their ratio (E/A ratio) was calculated.
Tissue doppler imaging
TDI of the mitral annulus was obtained from the apical
4-chamber view. The sample volume was placed sequen-
tially at the lateral and medial mitral annulus. The early
diastolic annular velocitiy (e’) was measured and ana-
lyzed as the average of the medial and lateral annulus.
The mitral inflow E velocity to tissue Doppler e’ (E/e’)
ratio, was calculated to estimate LV filling pressures.
VVI Image acquisition and offline analysis
ECG leads were connected to the paws. Digital dynamic
magnified loops of long- and short-axis views, incor-
porating at least three complete cardiac cycles, were re-
corded. The images were stored in DICOM format and
were analyzed off-line using Syngo VVI software. The
endocardium was manually traced, with the blood inter-
face of the left ventricles at end systole. On the three
long-axis (apical 2-, 3-, and 4-chamber) views, the endo-
cardium was manually traced, beginning with the free
wall edge of the atrioventricular valve annulus, extend-
ing to the apex, and returning to the septal edge of the
atrioventricular valve annulus, while on the three short-
axis (at the mitral valve, papillary muscle, and apex level)
views, the endocardium was manually traced beginning
with the anteroseptum and returning to the original lo-
cation in a clockwise direction. After placing the index
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the cycle for the short-axis views, VVI myocardial de-
formation analysis was then performed. Cardiac strain
and strain rates for systole and diastole were automatic-
ally calculated and were displayed in a six-segment
model. The peak systolic strain and the peak systolic and
diastolic strain rates were measured (Figure 1). Each
value was measured as the mean of three cardiac cycles.
Global longitudinal strain (GLS), systolic strain rate
(GLSRs), and diastolic strain rate (GLSRd) were displayed
as the average of all 18 segments of the three long-axis
(apical 2-, 3-, and 4-chamber) views, while global circum-
ferential strain (GCS), systolic strain rate (GCSRs), and
diastolic strain rate (GCSRd) were displayed as the average
of all 18 segments of the three short-axis (at the mitral
valve, papillary muscle, and apex) views.
Interobserver and intraobserver variability
Interobserver variability was assessed between two in-
dependent investigators (T.J. and L.Y.) on 20 randomly
selected data sets. To assess intraobserver variability, 10
randomly selected subjects were blindly analyzed three
times by one investigator (T.J.) within 1 week. Intra- and
inter-observer variabilities were then calculated as the
absolute differences between the corresponding two mea-
surements as the percentages of their means.
Histomorphological study of the heart
Two of the STZ-induced rabbits were killed at 2, 4, 8,
and 12 weeks after echocardiography. HistomorphologicalFigure 1 Representative strain and strain rate curves derived from VV
strain was measured (arrow). On the strain rate curve (B), the peak systolic
were measured.examination was performed after fixing the hearts of the
rabbits in 10% formalin and processing and embedding
them in paraffin. Tissue blocks were sectioned at a thick-
ness of 5 μm and were stained with Harris hematoxylin
and eosin (H&E).
Data analysis
The data are presented as the means ± standard devia-
tions (SDs) or are plotted as the means with SD bars.
The time-course changes in the DM group were as-
sessed using Scheffe’s test for multiple comparisons after
one-way analysis of variance. The unpaired two-tailed
Student's t-test for continuous variables was performed
between the DM and control groups at the same time
points. The differences between the longitudinal and cir-
cumferential parameters in the control group were as-
sessed by the paired t-test. A two-sided P < 0.05 was
considered statistically significant. All of the statistical
analyses were performed using the SPSS software pack-
age (SPSS for Windows; SPSS Inc., Chicago, IL, USA).
Results
General conditions
The rabbits in the DM group exhibited less activity
(tended to blink and move about less frequently), loss of
energy, and the presence of clinical symptoms of dia-
betes beginning on the fifth day post-injection. In the
DM group, one rabbit died within 8 hours after injec-
tion, and another died at 2 weeks. The rabbits in the
control group remained healthy, and none died. Thus,I in the short-axis view. On the strain curve (A), the peak systolic
strain rate (negative value) and diastolic strain rate (positive value)
Table 1 General conditions and routine echocardiographic parameters in the control and DM groups ()
Control group DM group
Baseline 2 weeks 4 weeks 8 weeks 12 weeks Baseline 2 weeks 4 weeks 8 weeks 12 weeks
Glucose (mg/dL) 92.34 ± 10.98 91.44 ± 16.56 93.06 ± 11.16 91.80 ± 14.76 87.66 ± 12.78 91.08 ± 10.08 409.14 ± 74.34* 409.50 ± 81.72* 418.5 ± 88.56* 424.44 ± 101.7*
HR (bpm) 235 ± 11 215 ± 10 219 ± 13 230 ± 14 227 ± 8 219 ± 6 225 ± 18 241 ± 10 239 ± 13 212 ± 8
LA (mm) 7.82 ± 0.61 7.58 ± 0.79 8.03 ± 0.62 7.69 ± 0.82 7.76 ± 0.47 7.52 ± 0.74 7.49 ± 0.62 7.78 ± 0.54 7.62 ± 0.50 11.57 ± 0.84*
LVDd (mm) 11.83 ± 1.10 11.65 ± 1.07 11.72 ± 1.82 11.47 ± 1.63 11.84 ± 1.40 11.92 ± 2.26 11.48 ± 0.91 11.57 ± 1.50 11.68 ± 1.34 13.69 ± 0.92*
LVDs (mm) 8.53 ± 1.35 8.29 ± 1.22 8.62 ± 1.10 8.71 ± 0.86 8.44 ± 1.52 8.29 ± 1.85 8.31 ± 1.03 8.49 ± 1.30 8.22 ± 1.53 10.38 ± 1.26*
LVPW (mm) 2.35 ± 0.43 2.24 ± 0.43 2.37 ± 0.39 2.45 ± 0.28 2.41 ± 0.51 2.40 ± 0.61 2.52 ± 0.23 2.48 ± 0.51 2.45 ± 0.59 3.36 ± 0.45*
IVS (mm) 2.29 ± 0.32 2.32 ± 0.36 2.30 ± 0.41 2.32 ± 0.42 2.25 ± 0.50 2.21 ± 0.62 2.34 ± 0.53 2.30 ± 0.57 2.33 ± 0.48 3.29 ± 0.39*
EF (%) 63.56 ± 5.53 60.75 ± 6.22 65.39 ± 3.82 62.77 ± 8.20 65.43 ± 4.82 62.58 ± 5.77 63.34 ± 4.92 61.89 ± 6.58 63.87 ± 4.52 44.77 ± 5.42*
FS (%) 31.59 ± 5.87 35.72 ± 4.39 35.01 ± 4.62 33.69 ± 5.28 32.49 ± 6.31 30.64 ± 5.52 32.41 ± 2.56 31.78 ± 2.69 32.52 ± 2.53 24.83 ± 4.48*
E/A 1.56 ± 0.51 1.4 ± 0.27 1.67 ± 0.33 1.55 ± 0.42 1.62 ± 0.22 1.53 ± 0.61 1.60 ± 0.48 1.57 ± 0.60 1.60 ± 0.23 0.75 ± 0.38*
E/e’ 3.1 ± 1.2 3.0 ± 0.6 3.0 ± 1.0 3.1 ± 0.8 3.0 ± 1.2 3.1 ± 1.1 3.3 ± 1.3 3.8 ± 1.8 6.1 ± 3.5* 8.7 ± 2.7*
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DM group were included in the analysis.
No significant baseline weight differences were observed
between the DM and control groups (2.03 ± 1.33 kg vs.
2.03 ± 1.14 kg, P > 0.05). As expected, the fasting blood
glucose in the DM group increased gradually and re-
mained greater than 300 mg/dL beginning one day after
injection, while the body mass in the DM group was sig-
nificantly lower than that in the control group at 12 weeks
after injection (3800.39 ± 23.42 g vs. 3392.23 ± 11.51 g,
P < 0.05).
Echocardiogram
In the control group, the echocardiographic parameters,
such as heart rate, LA diameter, LVESD, LVEDD, IVS
thickness, PW thickness, FS, EF, and E/A, E/e’remained
unchanged (Table 1).Figure 2 Time course changes in global longitudinal strain and strain
group based on ANOVA.In the DM group, before 12 weeks, the above-mentioned
parameters also remained constant except E/e’ increased at
8 weeks, while after 12 weeks, compared with the control
group, LA diameter, LVESD, LVEDD, IVS thickness, and
PW thickness were increased; FS, EF, and E/A were de-
creased (all P < 0.05).Velocity vector imaging parameters
In STZ-induced rabbits, 2 weeks later, global longitu-
dinal parameters, such as GLS, GLSRs, and GLSRd, were
significantly lower than those pre-injection (P < 0.05)
and those in the control group (P < 0.05) (Figure 2). At
8 weeks, compared with earlier time points in the DM
and control groups, the global circumferential parameters,
such as GCS, GCSRs, and GCSRd, in the DM group were
significantly decreased (P < 0.05, Figure 3). Moreover, asrate. *P < 0.05 versus the control group; &P < 0.05 versus the DM
Figure 3 Time course changes in global circumferential strain and strain rate. *P < 0.05 versus the control group; &P < 0.05 versus the DM
group based on ANOVA.
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with significance (P < 0.05).Histomorphological study
The heart sections of STZ-induced rabbits showed mild
edema and vacuolization in the cytoplasm after 2 weeks.
After 4 weeks, obvious edema, more vacuolization in the
cytoplasm, and a few hemorrhages were observed. Eight
weeks later, in addition to moderate vacuolization and
hemorrhage, histiocyte proliferation and interstitial fi-
brosis appeared. After 12 weeks, degenerative changes in
the nuclei, severe histiocyte proliferation, interstitial fi-
brosis, and collagen deposits were observed (Figure 4).Observer variability
The interobserver variability in the longitudinal and cir-
cumferential directions was 13% and 15% for strain, 6%
and 7% for the systolic strain rate, and 8% and 10% for
the diastolic strain rate, respectively. The intraobserver
variability was 9% and 10% for strain, 5% and 6% for the
systolic strain rate, and 6% and 5% for the diastolic
strain rate in the longitudinal and circumferential direc-
tions, respectively.
Discussion
The major findings of this study can be summarized as
follows: 1) in STZ-induced diabetic rabbits, global strain
and strain rates derived from VVI were significantly
Figure 4 Myocardial histoanatomical alterations in STZ-induced
DM rabbits. The heart sections of STZ-induced rabbits 2 weeks
following diabetes induction showed mild edema and minor
vacuolization in the cytoplasm. After 4 weeks, obvious edema, more
vacuolization in the cytoplasm, and a few hemorrhages were
observed. Eight weeks later, in addition to moderate vacuolization
and hemorrhage, histiocyte proliferation and interstitial fibrosis
appeared. After 12 weeks, degenerative changes in the nuclei, severe
histiocyte proliferation, interstitial fibrosis, and collagen deposits
were observed.
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before the onset of detectable changes in routine echo-
cardiographic parameters, such as EF, FS, and E/A; and 2)
progressive reductions in longitudinal strain and strain
rates started 6 weeks earlier than those in circumferential
strain and strain rates.
In the present study, conventional echocardiographic
parameters remained within normal ranges until 12 weeks
after the induction of diabetes, but profound decreases in
strain and strain rates appeared on VVI by 2–8 weeks
after diabetes induction. These findings suggest that both
systolic and diastolic LV myocardial performance were im-
paired in the early stage of T1DM, which was in agree-
ment with our histoanatomical results.
Diastolic dysfunction (DD) is the most frequent echo-
cardiographic finding in asymptomatic T1DM patients
with normal LVEF. DD in T1DM have mainly been exa-
mined by standard echocardiography parameters like E/A,
and also by tissue Doppler imaging like E/e’ [11-16]. Rou-
tine diastolic parameter E/A cannot distinguish pseudo-
normal and normal patterns of transmitral inflow because
of its preload dependence. The ratio E/e’ may be ex-
tremely useful for characterizing DD and LV filling pres-
sure because early diastolic peak velocity (e’) of the mitral
annulus reflects the rate of myocardial relaxation and is
relatively insensitive to preload effects [17] STZ-induced
T1DM rats and mice also exhibited impairments in dia-
stolic function, as shown on Doppler echocardiography(E/A, deceleration time, and IVRT) and cardiac catheteri-
zation (elevated LV end-diastolic pressure, LVEDP) in vivo
[18-20]. Our study showed E/A decreased at 12 weeks,
E/e’ increased and circumferential diastolic strain rate de-
creased at 8 weeks, longitudinal diastolic strain rate de-
creased at 2 weeks. The finding indicated diastolic strain
rate might be more sensitive to impaired left ventricular
diastolic function. Muranaka et al [21] demonstrated that
early diastolic circumferential strain rates were reduced in
diabetic patients using strain rate imaging. Wei Z et al
[8,9] reported that 12 weeks after STZ induction, cir-
cumferential diastolic strain rates of the mid-level wall
decreased mildly from 3.53−1 to 2.47−1. Hyperglycemia,
insulin resistance, sympathetic overdrive, endothelial dys-
function, abnormalities of the angiotensin-renin system
(ARS), and LV remodeling/hypertrophy may induce dia-
stolic dysfunction (DD) and impairment of the coronary
microcirculation and the microvascular alterations may
worsen DD in DM [17].
Although diastolic dysfunction has been described as
an early stage of diabetic heart disease progression in pa-
tients with normal LVEFs, preclinical systolic alteration
has also recently been described by strain. Labombarda
F’s study [10] demonstrated GLS was significantly lower
in the T1DM children and correlated with HbA1c. Sveen
KA [11] also reported LV longitudinal strain was signifi-
cantly reduced in the patients with T1DM compared to
controls. In an experimental rat study, Weytjens C et al
[22] detected, at 6 weeks after STZ injection, a lower
myocardial velocity and systolic strain rate and delayed
time-to-peak deformation on Doppler myocardial im-
aging. Wei Z et al [8,9] demonstrated that 12 weeks
after STZ induction, the circumferential strain of the
mid-level wall on the LV short-axis in diabetic rats
decreased mildly from −13.51% to −11.02%, and the
systolic circumferential strain rates decreased mildly
from −3.46−1 to −2.34−1. However, our study showed
that global circumferential strain decreased profoundly,
from −21.49% to −8.03%, and systolic global circumferen-
tial strain rates decreased from −2.04−1 to −0.82−1. Add-
itionally, global longitudinal strain and systolic strain rates
decreased substantially after 12 weeks, from −24.19%
to −6.09%, and −2.39−1 to −0.66−1. Differences between
the study animals and in the methods of measuring strain/
strain rate may account for the discrepancies between our
study and that by Wei Z et al. However, we were still un-
able to determine why DM induced a mild form of cardio-
myopathy in other animal studies but induced severe
dysfunction in our study.
Our study showed longitudinal strain, systolic strain
rate and diastolic strain rate decreased in the early stage
(even at 2 weeks) after STZ induction, suggesting im-
pairment of both contractile and diastolic function in
DM. Ernande L et al [23] reported that systolic alteration
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stolic function and in 35% of patients with diastolic
dysfunction. Systolic strain alteration can exist despite
normal diastolic function, indicating that diastolic dys-
function should not be considered the first marker of
the preclinical form of diabetic cardiomyopathy [23]. The
studies on T2DM also showed both global and regional
longitudinal strains were significantly reduced in patients
with DM with respect to controls [24]. Galderisi M’s study
[25] reported strain rate and strain were significantly
lower in diabetics at low-dose and high-dose dobutamine,
indicating altered contractile reserve in uncomplicated
diabetes. Additionally, Stanton T et al. underwent a study
on Prediction of all-cause mortality and demonstrated glo-
bal longitudinal strain measurement was superior to EF
and WMSI for the prediction of outcome and may be-
come the optimal method for assessment of global LV sys-
tolic function [26].
The metabolic features [27] of STZ-induced DM animals
include prompt development of profound hyperglycemia,
modest hypertriglyceridemia, ketosis, and markedly re-
duced plasma insulin levels. Disturbances in metabolism of
the heart have been implicated as important contributors
to diabetic cardiac complications. Impaired excitation-
contraction coupling (indicating by prolongation of action
potential duration, slowed decay and reduced amplitude
in Ca2+ transient, reduced Ca2+ sensitivity of contractile
proteins, reduced Ca2+ store in sarcoplasmic reticulum),
inefficient ATP production (indicating by increased free
fatty acid uptake, suppressed glucose oxidation, mitochon-
drial dysfunction), reduced coronary flow reserve (indicat-
ing by microangiopathy, reduced microvascular density,
impaired regulation of smooth muscle cell) and remod-
eling of extra-cellular matrix (indicating by increased
collagen deposition, increased cross-link of collagen and
laminin fibers) may cause left ventricular contractile dys-
function [28].
This study yielded another interesting finding, namely
that GLS and GLSR in the DM group decreased six
weeks earlier than the decrease in GCS and GCSR, sug-
gesting that longitudinal deformation occurred early in
the disease course, while circumferential deformation
occurred relatively late in the disease course. This find-
ing was in accordance with the document published by
the American Society of Echocardiography, the European
Society of Echocardiography, and the Japanese Society of
Echocardiography [29]. Additionally, unlike longitudinal
parameters, circumferential deformation serves as a mar-
ker of more advanced myocardial damage [30] and of
prognosis [31].
Conclusion
The present study demonstrated that DM rabbits with
apparently normal LV dimensions, EFs, and E/A hadimpaired myocardial function as measured by the 2D
speckle tracking-derived strain and strain rate. This
finding indicates that velocity and strain rate are more
sensitive and may be used for the detection of early LV
dysfunction in diabetes. Moreover, impaired longitudinal
myocardial deformation occurred earlier than circumfer-
ential dysfunction. As time passed, heart function and
structure underwent progressive adverse changes.
Limitations
First, because the myofibers are oriented parallel to the
ultrasound beam in the septal and lateral regions on the
short-axis views, the gray-scale quality can deteriorate in
these segments, further compromising the accuracy of
GCS and GCSR measurements. Second, the radial strain
and strain rate could not be measured. The myocardial
deformations in DM in the radial direction require fur-
ther research.
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